mRNA

Moderna Stock Plummets 16% After £819.59M Guidance Cut Over Respiratory Vaccine Flop

by
Moderna Stock Plummets 16% After £819.59M Guidance Cut Over Respiratory Vaccine Flop

Vaccine maker Moderna’s (NASDAQ: MRNA) stock prices fell by over 16% on 13th January to close at £28.81 ($35.15) after the company trimmed its 2025 revenue guidance to between £1.22 billion ($1.5 billion) and £2.04 billion ($2.5 billion) from its previous estimate between £2.04 billion ($2.5 billion) and £2.86 billion ($3.5 billion). Wall Street expected … Read more

Moderna, Merck Drugs Combined Shown Effective Against Melanoma

by
Moderna, Merck Drugs Combined Shown Effective Against Melanoma

U.S. pharmaceutical companies Moderna and Merck say a clinical trial for an experimental Moderna mRNA vaccine used in combination with the Merck cancer therapy drug Keytruda reduced the chance of recurrence or death from melanoma by nearly 50%. In a release from Moderna on Thursday, the company said the trial included 157 patients with high-risk … Read more